Belustine 40 Mg
Belustine 40 Mg containing the active ingredient lomustine is considered an alkylating agent type of medication. The medication works by slowing or stopping the growth of cancer cells as well as limiting them spreading throughout the body. Patients should use the medication to treat brain tumors and Hodgkin's disease when other types of treatment or medications have not improved their condition
Drug = Lomustine
Strength = 40 Mg
Manufacturer = Mediclone Pharmaceutical Ltd
How To Take
Belustine 40 Mg is usually taken orally once every 6 to 8 weeks or as directed by a doctor. To prevent nausea or vomiting, it is recommended to take the capsules on an empty stomach along with a glass of water. Contact a doctor for the correct dosage and length of treatment as it will depend on any other treatments, the patient's weight and their response to the therapy. Always swallow the capsules whole and not crush, chew or split it prior to consumption.
Belustine 40 Mg
Loss of appetite
Mouth or lip sores
Temporary hair loss
Unusual fatigue or weakness
Always wear rubber or latex gloves when handling the capsules to ensure it does not come into contact with the skin.
Immediately proceed to your nearest emergency department if you suffer an allergic reaction. Symptoms usually associated with such a reaction include difficulty breathing or swallowing, chest tightness, swelling, skin rashes, and hives.
Belustine 40 Mg is not always suitable for all patients. Always consult your health care provider prior to using this medication if you are pregnant, breastfeeding, trying to conceive, using any other medication (prescription or non-prescription), using any herbal products or supplements, or if you have any allergies or other health problems.
The correct dosage and prescription commonly depend on the patient and the condition being treated. Do not adjust your dosage without the approval of your health care provider. This product is only for use as prescribed and instructed.
Belustine 40 Mg (Lomustine) is a type of cancer medicine used for the palliative treatment of Hodgkin`s disease which is resistant to other drugs and primary or metastatic brain tumors. Its mechanism of action is affecting the proliferation of cancer cells. Patients are either treated with this medicine alone (monotherapy) or else given it alongside radiotherapy, surgery or a treatment regimen involving multiple chemotherapy drugs. Other uses include treating tumors affecting the lung, malignant melanoma, non-Hodgkin`s lymphoma (as a second line treatment), gastrointestinal tumors, kidney cancer, breast cancer, multiple myeloma and some conditions not listed here.